US OptionsDetailed Quotes

NVO241220P134000

Watchlist

0.00
0.000.00%

15min DelayClose Dec 27 09:30 ET

0.00High0.00Low

Novo-Nordisk A/S Stock Discussion

102875548

Yesterday 06:09

Contrian Mindset?

$Novo-Nordisk A/S (NVO.US)$
🔬🔬🔬👇🏻🤔
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades | The Motley Fool
Will the medical industry still give it out? 🔮🔮🔮
Anybody with medical experience, please share.

Yolion

Dec 27 07:35

$Novo-Nordisk A/S (NVO.US)$

pootpoot

Dec 27 03:41

$Novo-Nordisk A/S (NVO.US)$ premarket bulltrap

pootpoot

Dec 23 08:48

$Novo-Nordisk A/S (NVO.US)$
it was fun..

Share Your Profit/Loss

Movers and Shakers

Dec 23 07:35

Columns Today's Pre-Market Movers and Top Ratings | NVO, TSLA, TRAW and More

Morning Movers
Gapping up
$Novo-Nordisk A/S (NVO.US)$ shares rose 5%, recovering from an 18% drop in the previous session after its weight loss drug, CagriSema, posted disappointing late-stage trial results on Friday.
$Tesla (TSLA.US)$ gained 3% premarket, recovering from last week's 3.5% drop, its worst performance since before the U.S. presidential election.
$Traws Pharma (TRAW.US)$ shares surged 109% after announcing progress on...

Money Thrill

Dec 23 07:20

What to understand about statistics ?

$Novo-Nordisk A/S (NVO.US)$ Statistics are always open to interpretation. Never a 100 percent correct evaluation. In doing so, Novo also point out a number of RESEARCH LIMITATIONS. Less than SIX out of TEN obese patients would have used the highest permitted dose. Nevertheless, Novo Nordisk will ask the regulators of the pharmaceutical industry to allow the drug for commercialization.
So, would you care if a weight loss supplement only achieved a 22.7% weight ...

Ho Lee Fuk

Dec 23 02:45

$Novo-Nordisk A/S (NVO.US)$ 150 by this year

102532025

Dec 23 02:30

$Novo-Nordisk A/S (NVO.US)$ why the drop

AusMario838

Dec 21 20:43

$Novo-Nordisk A/S (NVO.US)$ Waoooo so cheapp now

Ultratech

Dec 21 12:14

$Novo-Nordisk A/S (NVO.US)$
no idea whats up w/ nvo for entry but nvox is a new leaveraged ticker. it just started recently so hadn't had a chance to go up yet before tanking. this is the complete history of ticker.
$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$

Money Thrill : Good drop is an Good buy now. Analysts do not know anything about this company and others medicines? Also about statistics... never believe them ? Shall explain later, first buy

Report
Reply

Cancel Reply
Ultratech OP Money Thrill : well i don't know anything about them either so idk if it's a good buy now or if should wait

Report
Reply

Cancel Reply
Money Thrill : I suppose it is now the moment, the next days to follow and buy. I have many articles of it, investments, new drugs etc ... And about the statistics? Here better information.
A pipeline, one that built on the previous blockbusters. But the latest research results were disappointing. A test with some 3,400 patients led to an average weight loss of 22.7% after 68 weeks, which was less than the 25% the company had expected. It scored "only as well" as Zepbound from competitor Eli Lilly, which is already on the market.
Nevertheless, Novo Nordisk will ask the regulators of the pharmaceutical industry to allow the drug to be commercialized. In doing so, they also point to a number of research limitations. Fewer than six out of ten obese patients are said to have used the highest permitted dose.
Investors reacted negatively and immediately pressed the sell button. Yesterday, the share fell almost 21% to 589.20 Danish krone (79 euros). In trading, it had briefly lost almost 30%.

Report
Reply

Cancel Reply
Ultratech OP Money Thrill : I'm saying for others who may be looking at the leaveraged etf i posted. medical/bio stuff isn't my thing

Report
Reply

Cancel Reply
Money Thrill : All statistics are subject to interpretation... limitations? So, never 100% reliable !!! But it is better so, if they wants to regulate it in US ? Lesser than Eli Lilly ".... reading between the lines .... "

Report
Reply

Cancel Reply

View more comments...

No comment yet